Cargando…

Abnormal peripheral chemokine profile in Huntington’s disease

Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by both neurological and systemic abnormalities. Immune activation is a well-established feature of the HD brain and we have previously demonstrated a widespread, progressive innate immune response detectable in plasm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wild, Edward, Magnusson, Anna, Lahiri, Nayana, Krus, Ulrika, Orth, Michael, Tabrizi, Sarah J, Björkqvist, Maria
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Huntington Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082446/ https://www.ncbi.nlm.nih.gov/pubmed/21826115 http://dx.doi.org/10.1371/currents.RRN1231

Ejemplares similares

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

Stability of white matter changes related to Huntington’s disease in the presence of imaging noise: a DTI study
por: Müller, Hans-Peter, et al.
Publicado: (2011)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Drosophila Models of Huntington's Disease Exhibit Sleep Abnormalities
por: Gonzales, Erin, et al.
Publicado: (2010)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington’s Disease
por: Oakeshott, Stephen, et al.
Publicado: (2011)

NMDA receptor gene variations as modifiers in Huntington disease: a replication study
por: Saft, Carsten, et al.
Publicado: (2011)

Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington’s disease
por: Müller, Hans-Peter, et al.
Publicado: (2012)

No evidence of impaired gastric emptying in early Huntington‘s Disease
por: Saft, Carsten, et al.
Publicado: (2011)

Aspiration pneumonia and death in Huntington’s disease
por: Heemskerk, Anne-Wil, et al.
Publicado: (2012)

Music perception and movement deterioration in Huntington’s disease
por: Beste, Christian, et al.
Publicado: (2011)

Advocacy Recruiting for Huntington’s Disease Clinical Trials
por: Goodman, LaVonne, et al.
Publicado: (2011)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Assessment of Cognitive Symptoms in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

QEEG Measures in Huntington's Disease: A Pilot Study
por: Hunter, Aimee, et al.
Publicado: (2010)

Utilisation of Healthcare and Associated Services in Huntington’s disease: a data mining study
por: Busse, Monica, et al.
Publicado: (2011)

Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
por: Goodman, Anna O. G., et al.
Publicado: (2011)

Identifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnaire
por: Goodman, Anna O. G., et al.
Publicado: (2010)

Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington’s disease.
por: Schroeder, Analyne M., et al.
Publicado: (2011)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington’s Disease
por: Rao, Ashwini K., et al.
Publicado: (2011)

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease
por: Groves, Mark, et al.
Publicado: (2011)

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease
por: Burgunder, Jean-Marc, et al.
Publicado: (2011)

Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Huntington's like conditions in China, A review of published Chinese cases
por: Zheng, Zhenzhen, et al.
Publicado: (2012)

The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis
por: Quarrell, Oliver, et al.
Publicado: (2012)

Cognitive follow up of a small cohort of Huntington’s disease patients over a 5 year period.
por: Mason, Sarah L, et al.
Publicado: (2010)

An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington’s Disease
por: Anderson, Karen, et al.
Publicado: (2011)

Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice
por: Renoir, Thibault, et al.
Publicado: (2011)

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
por: Zhang, Ningzhe, et al.
Publicado: (2010)

Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington’s disease
por: Potter, Michelle C, et al.
Publicado: (2010)

Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions"
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease
por: Aylward, Elizabeth, et al.
Publicado: (2011)

Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice
por: Im, Wooseok, et al.
Publicado: (2010)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
por: Dorsey, Ray, et al.
Publicado: (2011)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4e8b7okjo0ho9iseh7a66jt1l6